A couple of months ago, we had given an outlook for the Nifty 50. Today, we’re giving an update to that Nifty 50 outlook. Here
In these reviews, we pick stocks that have rallied, or where businesses are interesting or changing, or where companies may be relatively unknown and so
Even as the economy is battling with the second wave of Covid-19, supply chain appears to be smoother than when the pandemic began. After 2
The stock of Tata Steel Long Products (TSLP) offers an interesting case study on how a commodity business in an unexciting category can acquire scale,
In these reviews, we pick stocks that have rallied, or where businesses are interesting or changing, or where companies may be relatively unknown and so
The benchmark Nifty 50 index has been drifting lower since February 16, 2021 when it recorded a high of 15,431.8. While there has been some recovery in the past few weeks, the real action has shifted to the broader markets. Lots of stocks from the mid-cap and small-cap sectors have continued to seek higher levels even as the Nifty 50 index has been struggling in a broad range.
Price to Book Value (P/BV) ratio is a measurement of how much an investor pays for a stock over its book value. Book value is
Many years ago, I asked a fund manager about why did he not exit a lot of his portfolio and keep cash, since it was obvious that stock valuations were rather high. His response was that the investor has given him money to invest in equities, which made up his or her ‘equity’ allocation and therefore he was duty bound to keep it invested fully.
Most of the FMCG majors posted stellar numbers for the March 2021 quarter. But this performance has come by mainly due to favourable base effect.
This is Part II of our series on REITs. You can find the first part here. Apart from a secret passion for owning real estate,
Growth estimates are being placed at a CAGR of around 10% for the next five years for the diagnostics sector, presenting a very attractive opportunity to players that are ready and able to take advantage. Dr Lal Path Labs is a leading diagnostics player, building up its presence outside its traditional stronghold of Delhi.
In bull markets, expensive valuations often make it necessary for investors to look for offbeat opportunities to acquire a wealth generating company. The investment arms of leading promoter groups in India offer such opportunities to buy sound companies, at a discount to prevailing valuations.
Hold On
You are being redirected to another page,
Elevate Your Wealth with Professional Portfolio Management
